| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
49 | 4,483 | 9,198 | 17,477 | 12,179 |
| Selling, General and Administrative Expenses
|
-61,915 | -53,892 | -17,099 | -15,607 | -15,276 |
|
Operation and Maintenance Expenses
|
0 | 0 | 0 | 0 | 0 |
|
Research and Development Expenses
|
-88,391 | -87,043 | -90,880 | -110,012 | -60,469 |
| Depreciation, Amortization and Depletion
|
-319 | -253 | -694 | -209 | -220 |
|
Taxes Other Than Income Taxes
|
-- | -- | -- | 0 | 0 |
| Provision Expense/Write-Back
|
348 | 381 | 0 | 0 | 294 |
| Other Income/Expense, Operating
|
3,569 | 3,441 | 5,486 | 5,686 | 6,635 |
|
Operating Income/Expenses
|
-146,708 | -137,366 | -103,187 | -120,142 | -69,036 |
|
Total Operating Profit/Loss
|
-146,659 | -132,883 | -93,989 | -102,665 | -56,857 |
| Total Net Finance Income/Expense
|
-34,438 | -30,678 | -11,069 | -4,233 | -364 |
| Net Investment Income
|
-58,377 | -182,423 | -75,274 | -2,876 | 3,057 |
| Irregular Income/Expenses
|
-7,616 | -8,129 | -3,569 | -44 | -130 |
|
Non-Operating Income/Expenses, Total
|
-100,431 | -221,230 | -89,912 | -7,153 | 2,563 |
|
Pretax Income
|
-247,090 | -354,113 | -183,901 | -109,818 | -54,294 |
|
Provision for Income Tax
|
-629 | -22 | -313 | -607 | 20 |
|
Net Income from Continuing Operations
|
-247,719 | -354,135 | -184,214 | -110,425 | -54,274 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-247,719 | -354,135 | -184,214 | -110,425 | -54,274 |
|
Net Income after Non-Controlling/Minority Interests
|
-247,723 | -354,138 | -184,212 | -110,426 | -54,274 |
|
Net Income Available to Common Stockholders
|
-247,723 | -354,138 | -184,212 | -110,426 | -54,274 |
|
Diluted Net Income Available to Common Stockholders
|
-247,723 | -354,138 | -184,212 | -110,426 | -54,274 |
| Basic EPS
|
-0.53 | -1.90 | -3.08 | -2.43 | -1.31 |
| Diluted EPS
|
-0.53 | -1.90 | -3.08 | -2.43 | -1.31 |
|
Basic Weighted Average Shares Outstanding
|
269,173.4090 | 186,801.7920 | 59,778.7010 | 45,351.7990 | 41,449.7320 |
|
Diluted Weighted Average Shares Outstanding
|
269,173.4090 | 186,801.7920 | 59,778.7010 | 45,351.7990 | 41,449.7320 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-212,696 | -323,494 | -172,866 | -105,631 | -53,977 |
|
EBITDA
|
-212,028 | -320,271 | -167,668 | -103,032 | -52,279 |
|
Normalized EBITDA
|
-86,147 | -104,237 | -85,398 | -98,333 | -49,181 |
|
Normalized Income
|
-153,308.2500 | -192,109.5000 | -122,511.5000 | -106,900.7500 | -51,177.8588 |
12/31/2022 - 2/15/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade